Product NDC: | 55390-185 |
Proprietary Name: | Butorphanol Tartrate |
Non Proprietary Name: | Butorphanol Tartrate |
Active Ingredient(s): | 2 mg/mL & nbsp; Butorphanol Tartrate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-185 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075046 |
Marketing Category: | ANDA |
Start Marketing Date: | 19981015 |
Package NDC: | 55390-185-10 |
Package Description: | 1 VIAL in 1 BOX (55390-185-10) > 10 mL in 1 VIAL |
NDC Code | 55390-185-10 |
Proprietary Name | Butorphanol Tartrate |
Package Description | 1 VIAL in 1 BOX (55390-185-10) > 10 mL in 1 VIAL |
Product NDC | 55390-185 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Butorphanol Tartrate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19981015 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | BUTORPHANOL TARTRATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |